The International Association for the Study of Lung Cancer (IASLC) is committed to keeping its members, the medical community and the public informed about the latest in lung cancer research. Please contact us for information or to schedule an interview with a lung cancer expert.
Media registration opens for World Conference on Lung Cancer (May 16, 2013)
Leading health care organizations issue guideline recommendations for molecular testing and target therapies (April 3, 2013)
Application process open for Advocacy Travel Awards (April 2, 2013)
IASLC names Dr. Alex Adjei JTO Editor-in-Chief (Dec. 2012)
Lung Cancer Awareness Month (Nov. 1, 2012)
Lung cancer mortality rates linked to primary care provider density (April 22, 2013)
Tumors with ALK rearrangements can harbor more mutations (April 22, 2013)
Many doctors do not provide tobacco cessation assistance to lung cancer patients (March 28, 2013)
Pathologists identify patterns of mutations to help inform design of future trials (March 22, 2013)
Local therapy followed by treatment with EGFR TKI is well tolerated (Feb. 22, 2013)
Greater representation of elderly patients in Phase III trails are needed (Feb. 22, 2013)
EGFR mutation not prognostic factor in non-small cell lung cancer (Jan. 15, 2013)
Patients with EGFR exon 20 insertions have poorer prognosis (Jan. 15, 2013)
Comparable patterns of failure between SBRT, Lobectomy or pneumonectomy for stage I non-small cell lung cancer (Jan. 15, 2013)